Anastasia Mylonas Baumeister Joins Institute for Myeloma & Bone Cancer Research Board

A growing trend in non-profit cancer research, board members who dedicate philanthropy in honor of a loved one who died from the disease. While multiple myeloma survival rates have increased, the need for continued research is a commitment for some.

The Institute for Myeloma and Bone Cancer Research is an independent, non-profit cancer research institute dedicated to finding a cure for multiple myeloma, a plasma cell cancer found in bone marrow. More than 100,000 people are diagnosed with myeloma every year and it is estimated that more than 1,000,000 are living with myeloma worldwide. IMBCR was founded in 2004 by leading myeloma researcher and oncologist, Dr. James R. Berenson whose research in both the clinic and the laboratory has spanned more than 25 years. Research conducted at IMBCR has created many of the novel-therapeutics used for myeloma patients worldwide.

Anastasia "Stacey" Mylonas Baumeister is an attorney who most recently served as a principal specializing in Labor Law with Knapp, Petersen & Clarke in Glendale, California. She serves on the board of directors for the Institute for Myeloma and Bone Cancer Research as a tribute to and in memory of her late father, Rev. Fr. Efsathios V. Mylonas, Ph.D., of St. Anthony Greek Orthodox Church in Pasadena, California who died of multiple myeloma.

In accepting her board appointment, Ms. Mylonas Baumeister said, "During my father's 11 year fight with multiple myeloma, I focused on learning as much as I could about the disease and all the available therapies and treatments for the disease. I witnessed, firsthand, the devastating effects that multiple myeloma can have on a person's body and ultimately, life. My father's death, however, only strengthened my resolve to fight this disease and ever since, I have stayed up to date on the emerging treatments and am looking forward to working with the Board of the Institute for Myeloma and Bone Cancer Research as a way to contribute to my father's dream that a cure will be discovered."

The Institute for Myeloma and Bone Cancer Research is headquartered in Los Angeles, CA. IMBCR research is funded in part by donations from major foundations, including the Annenberg, Skirball, Lincy and Kramer Family Foundations, FJC, (A Foundation of Philanthropic Funds), Multiple Myeloma Research Foundation and Myeloma Research Fund.

Collaborative research is also sponsored by major pharmaceutical companies. IMBCR research findings have been presented at annual meetings throughout the world. IMBCR research has been published in most major oncology journals.